A Mouse Model of MHV‐1 Virus Infection for Study of Acute and Long COVID Infection

Abstract

AbstractCOVID‐19, caused by SARS‐CoV‐2, has had a significant global impact. While vaccines and treatments have reduced severe cases and deaths, the long‐term effects are not yet well understood. Current models used for research, such as non‐human primates and transgenic mice, are expensive and require scarce Biosafety Level‐3 (BSL‐3) laboratories, thereby limiting their practicality. However, the mouse hepatitis virus 1 (MHV‐1) mouse model offers a promising alternative. This surrogate model can be investigated in more widely available Biosafety Level‐2 (BSL‐2) laboratories. Furthermore, mice are affordable and easy to handle, and utilizing MHV‐1 as a surrogate for SARS‐CoV‐2 eliminates the need for costly transgenic mice. Importantly, the MHV‐1 model successfully recapitulates COVID‐19‐related clinical symptoms, weight loss, multiorgan pathological changes and failure in acute stages, irreversible neurological complications, and other long‐term organ dysfunction post‐infection, which are similar to available human data post‐COVID‐19. To assist researchers in establishing and using the MHV‐1 mouse model, this protocol offers comprehensive guidance encompassing procedures for animal preparation, induction of viral infection, clinical observation, pathological changes, and tissue analysis for mechanistic studies, thereby yielding valuable insights into disease mechanisms and progression. By adopting the MHV‐1 model and the provided protocols, researchers can effectively circumvent financial constraints and the limited availability of BSL‐3 laboratories, thus facilitating a more accessible and cost‐effective approach to investigating the underlying mechanisms of SARS‐CoV‐2 pathophysiology and exploring potential therapeutic interventions. © 2023 Wiley Periodicals LLC.Basic Protocol: Induction of mouse hepatitis virus 1 (MHV‐1) infection in A/J miceSupport Protocol 1: Histological evaluationSupport Protocol 2: Liver enzyme measurementSupport Protocol 3: Western blot analysis of aquaporin expressionSupport Protocol 4: mRNA measurementSupport Protocol 5: Immunohistochemistry/immunofluorescenceSupport Protocol 6: Tissue water measurement